| | 129318-43-0 Basic information More.. |
| Product Name: | Alendronate sodium | | Synonyms: | Alendronic acid, sodiuM salt;sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate;tetrasodium 4-amino-1,1-diphosphonato-butan-1-ol;tetrasodium 4-amino-1,1-diphosphonatobutan-1-ol;(4-Amino-1-hydroxybutylidene) bisphosphonic acid monosodium salt;4-AMINO-1-HYDROXY-1-PHOSPHONOBUTYL PHOSPHONIC ACID, MONOSODIUM;MK-217;Alendronate sodium | | CAS: | 129318-43-0 | | MF: | C4H13NNaO7P2 | | MW: | 272.09 | | EINECS: | 603-329-3 | | Mol File: | 129318-43-0.mol |  |
Use
Alendronate sodium is the world's most widely used anti-osteoporosis drugs, listed in the united states in 1993. it can significantly increase bone mineral density, reduce fracture risk, and it is the first-line treatment of osteoporosis drugs. alendronate sodium is a resorption inhibitor of aminodiphosphonate bone, and has a strong affinity with bone hydroxyapatite. it can enter the bone matrix hydroxyapatite crystals. when the osteoclast dissolved crystals, the drug was released, causing the inhibition of osteoclast activity, and playing anti-bone resorption activity indirectly through the inhibition of bone resorption of osteoblasts. it possesses the characteristics of the activity of anti-bone resorption and with no bone mineralization.
- Alendronate sodium
-
- 2025-05-12
- CAS:129318-43-0
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 500kgs
|
|
129318-43-0
Recommend Suppliers |
|